Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine.
Saved in:
| Title: | Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine. |
|---|---|
| Authors: | Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. Lisa.A.Jackson@kp.org., Coler RN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA., Deye GA; Parasitology & International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.; AstraZeneca LP, Wilmington, USA., Carter D; PAI Life Sciences Inc, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Gray SA; PAI Life Sciences Inc, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA., Pecor T; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA., Davis J; PAI Life Sciences Inc, Seattle, WA, USA., Larsen SE; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA., Posavad CM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Cox C; The Emmes Company, Rockville, MD, USA., Watanabe A; The Emmes Company, Rockville, MD, USA., Lundeen JS; The Emmes Company, Rockville, MD, USA., Gill R; Parasitology & International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Kalyanasundaram A; Department of Immunology & Molecular Microbiology and Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, USA., Siddiqui AA; Department of Immunology & Molecular Microbiology and Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, USA. |
| Source: | NPJ vaccines [NPJ Vaccines] 2025 Nov 24; Vol. 10 (1), pp. 247. Date of Electronic Publication: 2025 Nov 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41285840 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jackson+LA%22">Jackson LA</searchLink>; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. Lisa.A.Jackson@kp.org.<br /><searchLink fieldCode="AU" term="%22Coler+RN%22">Coler RN</searchLink>; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Deye+GA%22">Deye GA</searchLink>; Parasitology & International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.; AstraZeneca LP, Wilmington, USA.<br /><searchLink fieldCode="AU" term="%22Carter+D%22">Carter D</searchLink>; PAI Life Sciences Inc, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Gray+SA%22">Gray SA</searchLink>; PAI Life Sciences Inc, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Pecor+T%22">Pecor T</searchLink>; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Davis+J%22">Davis J</searchLink>; PAI Life Sciences Inc, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Larsen+SE%22">Larsen SE</searchLink>; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle Children's Hospital, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Posavad+CM%22">Posavad CM</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Cox+C%22">Cox C</searchLink>; The Emmes Company, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Watanabe+A%22">Watanabe A</searchLink>; The Emmes Company, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lundeen+JS%22">Lundeen JS</searchLink>; The Emmes Company, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gill+R%22">Gill R</searchLink>; Parasitology & International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kalyanasundaram+A%22">Kalyanasundaram A</searchLink>; Department of Immunology & Molecular Microbiology and Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, USA.<br /><searchLink fieldCode="AU" term="%22Siddiqui+AA%22">Siddiqui AA</searchLink>; Department of Immunology & Molecular Microbiology and Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2025 Nov 24; Vol. 10 (1), pp. 247. <i>Date of Electronic Publication: </i>2025 Nov 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41285840 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-025-01261-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 247 Titles: – TitleFull: Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jackson LA – PersonEntity: Name: NameFull: Coler RN – PersonEntity: Name: NameFull: Deye GA – PersonEntity: Name: NameFull: Carter D – PersonEntity: Name: NameFull: Gray SA – PersonEntity: Name: NameFull: Pecor T – PersonEntity: Name: NameFull: Davis J – PersonEntity: Name: NameFull: Larsen SE – PersonEntity: Name: NameFull: Posavad CM – PersonEntity: Name: NameFull: Cox C – PersonEntity: Name: NameFull: Watanabe A – PersonEntity: Name: NameFull: Lundeen JS – PersonEntity: Name: NameFull: Gill R – PersonEntity: Name: NameFull: Kalyanasundaram A – PersonEntity: Name: NameFull: Siddiqui AA IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 11 Text: 2025 Nov 24 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2059-0105 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |